Sandesh Mahatme, Senior Vice President, CFO at Sarepta Therapeutics, Inc. (SRPT), bought 5,000 shares at $31.10 ($156K) on 2013-08-20, disclosed to the SEC on 2013-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SRPT | SELL | 2019-02-01 | $8.5M | — | Filing → |
| SRPT | SELL | 2018-10-26 | $27.5M | — | Filing → |
| SRPT | SELL | 2017-07-21 | $2.0M | — | Filing → |